Perspective on National Coverage Analysis of CAR-T Therapies

New England Journal of Medicine
August 15, 2018

In Perspective piece published in the New England Journal of Medicine (NEJM), Dr. Bach lays out potential strategies for CMS’s evaluation of coverage and payment for the various CAR-T therapies. Table below¬†outlines alternative approaches to coverage for CAR-T therapies based on two key factors: similarity in net benefit and ancillary cost.



View original article here.